欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/1277/001
药品名称Cyclophosphamide 200 mg Powder for solution for injection/infusion
活性成分
    • Cyclophosphamide 200.0 mg
剂型Powder for solution for injection/infusion
上市许可持有人Seacross Pharma (Europe) Limited Pod 13, The Old Station House, 15a Main Street, Blackrock, Dublin, A94 T8P8, Ireland
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Germany (DE)
      Cyclophosphamid Seacross 200 mg Pulver zur Herstellung einer Injektions-/Infusionslösung
许可日期2024/10/23
最近更新日期2024/10/23
药物ATC编码
    • L01AA01 cyclophosphamide
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase